These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35202553)

  • 1. A Randomized Controlled Clinical Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea.
    Hedner J; Stenlöf K; Zou D; Hoff E; Hansen C; Kuhn K; Lennartz P; Grote L
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1461-1469. PubMed ID: 35202553
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetazolamide Reduces Blood Pressure and Sleep-Disordered Breathing in Patients With Hypertension and Obstructive Sleep Apnea: A Randomized Controlled Trial.
    Eskandari D; Zou D; Grote L; Hoff E; Hedner J
    J Clin Sleep Med; 2018 Mar; 14(3):309-317. PubMed ID: 29510792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.
    Altree TJ; Aishah A; Loffler KA; Grunstein RR; Eckert DJ
    J Clin Sleep Med; 2023 Jan; 19(1):85-96. PubMed ID: 36004739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep Apnea Multilevel Surgery (SAMS) trial protocol: a multicenter randomized clinical trial of upper airway surgery for patients with obstructive sleep apnea who have failed continuous positive airway pressure.
    Carney AS; Antic NA; Catcheside PG; Li Chai-Coetzer C; Cistulli PA; Kaambwa B; MacKay SG; Pinczel AJ; Weaver EM; Woodman RJ; Woods CM; McEvoy RD
    Sleep; 2019 Jun; 42(6):. PubMed ID: 30945740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trazodone Effects on Obstructive Sleep Apnea and Non-REM Arousal Threshold.
    Smales ET; Edwards BA; Deyoung PN; McSharry DG; Wellman A; Velasquez A; Owens R; Orr JE; Malhotra A
    Ann Am Thorac Soc; 2015 May; 12(5):758-64. PubMed ID: 25719754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial.
    Latshang TD; Nussbaumer-Ochsner Y; Henn RM; Ulrich S; Lo Cascio CM; Ledergerber B; Kohler M; Bloch KE
    JAMA; 2012 Dec; 308(22):2390-8. PubMed ID: 23232895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Multilevel Upper Airway Surgery vs Medical Management on the Apnea-Hypopnea Index and Patient-Reported Daytime Sleepiness Among Patients With Moderate or Severe Obstructive Sleep Apnea: The SAMS Randomized Clinical Trial.
    MacKay S; Carney AS; Catcheside PG; Chai-Coetzer CL; Chia M; Cistulli PA; Hodge JC; Jones A; Kaambwa B; Lewis R; Ooi EH; Pinczel AJ; McArdle N; Rees G; Singh B; Stow N; Weaver EM; Woodman RJ; Woods CM; Yeo A; McEvoy RD
    JAMA; 2020 Sep; 324(12):1168-1179. PubMed ID: 32886102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial.
    Nussbaumer-Ochsner Y; Latshang TD; Ulrich S; Kohler M; Thurnheer R; Bloch KE
    Chest; 2012 Jan; 141(1):131-138. PubMed ID: 21659435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of oxygen therapy for patients who do not respond to upper airway surgery for obstructive sleep apnea.
    Joosten SA; Tan M; Wong AM; Landry SA; Leong P; Sands SA; Beatty C; Thomson L; Stonehouse J; Turton A; Hamilton GS; Edwards BA
    J Clin Sleep Med; 2021 Mar; 17(3):445-452. PubMed ID: 33094725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults.
    Winslow DH; Bowden CH; DiDonato KP; McCullough PA
    Sleep; 2012 Nov; 35(11):1529-39. PubMed ID: 23115402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Supplemental Oxygen on Blood Pressure in Obstructive Sleep Apnea (SOX). A Randomized Continuous Positive Airway Pressure Withdrawal Trial.
    Turnbull CD; Sen D; Kohler M; Petousi N; Stradling JR
    Am J Respir Crit Care Med; 2019 Jan; 199(2):211-219. PubMed ID: 30025470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast for Children with Obstructive Sleep Apnea: Results of a Double-Blind, Randomized, Placebo-Controlled Trial.
    Kheirandish-Gozal L; Bandla HP; Gozal D
    Ann Am Thorac Soc; 2016 Oct; 13(10):1736-1741. PubMed ID: 27439031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.
    Dauvilliers Y; Verbraecken J; Partinen M; Hedner J; Saaresranta T; Georgiev O; Tiholov R; Lecomte I; Tamisier R; Lévy P; Scart-Gres C; Lecomte JM; Schwartz JC; Pépin JL;
    Am J Respir Crit Care Med; 2020 May; 201(9):1135-1145. PubMed ID: 31917607
    [No Abstract]   [Full Text] [Related]  

  • 15. Mandibular advancement device vs. CPAP in the treatment of obstructive sleep apnea: are they equally effective in Short term health outcomes?
    White DP; Shafazand S
    J Clin Sleep Med; 2013 Sep; 9(9):971-2. PubMed ID: 23997711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Combination of Supplemental Oxygen and a Hypnotic Markedly Improves Obstructive Sleep Apnea in Patients with a Mild to Moderate Upper Airway Collapsibility.
    Edwards BA; Sands SA; Owens RL; Eckert DJ; Landry S; White DP; Malhotra A; Wellman A
    Sleep; 2016 Nov; 39(11):1973-1983. PubMed ID: 27634790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA.
    Rosenberg R; Abaluck B; Thein S
    J Clin Sleep Med; 2022 Dec; 18(12):2837-2844. PubMed ID: 35975547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of nasal continuous airway pressure therapy in patients with obstructive sleep apnea.
    Kandasamy G; Almaghaslah D; Sivanandy P; Arumugam S
    Int J Health Plann Manage; 2019 Apr; 34(2):e1200-e1207. PubMed ID: 30793369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of insomnia and depression contributes to the acceptance of an initial treatment trial of continuous positive airway pressure therapy in patients with obstructive sleep apnea.
    Drakou T; Steiropoulos P; Saroglou M; Georgopoulou A; Kazis D; Papagiannopoulos S; Porpodis K; Tryfon S
    Sleep Breath; 2021 Dec; 25(4):1803-1812. PubMed ID: 33411189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term obstructive sleep apnea therapy: a 10-year follow-up of mandibular advancement device and continuous positive airway pressure.
    Uniken Venema JAM; Doff MHJ; Joffe-Sokolova D; Wijkstra PJ; van der Hoeven JH; Stegenga B; Hoekema A
    J Clin Sleep Med; 2020 Mar; 16(3):353-359. PubMed ID: 31992403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.